New plague test could speed up diagnosis in remote congo
NCT ID NCT07174648
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new rapid diagnostic test for plague in the Ituri province of DR Congo. Researchers will collect samples like blood, saliva, and bubo fluid from 300 people with suspected plague to see how well the new test works compared to standard lab methods. The goal is to help doctors diagnose plague faster and learn more about how the disease spreads.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Duplex F1V rapid diagnostic test (RDT)
- What this could lead to
- If successful, this test could help doctors diagnose plague faster and more easily in remote areas, potentially saving lives by enabling quicker treatment.
- What could go wrong
- This is an early field evaluation with only 300 participants, so the test may not perform as well in real-world conditions. It is not a treatment study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BUBONIC; PLAGUE, SKIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre De Recherche en Maladies Tropicales De L'ituri
Rethy, Democratic Republic of the Congo
More trials for these conditions
Other studies related to the condition(s) this trial covers.